Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free BEAM Stock Alerts

Beam Therapeutics (BEAM) Short Interest Ratio & Short Volume

Beam Therapeutics logo
$35.82 -1.06 (-2.87%)
Closing price 04:00 PM Eastern
Extended Trading
$36.10 +0.28 (+0.78%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Beam Therapeutics Short Interest Overview

As of June 15, 2026, Beam Therapeutics (BEAM) had a short interest of 28.31 million shares sold short, representing 28.60% of the public float. This marks a 31.94% increase in short interest since the prior report. The short interest ratio (days to cover) is 14.2, meaning it would take 14.2 days of the average trading volume of 2.44 million shares to cover all short positions.

Current Short Interest
28,309,079 shares
Previous Short Interest
21,455,853 shares
Change Vs. Previous Month
31.94%
Dollar Volume Sold Short
$880.98 million
Short Interest Ratio
14.2 Days to Cover
Last Record Date
June 15, 2026
Outstanding Shares
102,880,000 shares
Short Percent of Float
28.60%
Today's Trading Volume
2,504,229 shares
Average Trading Volume
2,441,703 shares
Today's Volume Vs. Average
103%
Short Selling Beam Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Beam Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BEAM Short Interest Over Time

BEAM Days to Cover Over Time

BEAM Percentage of Float Shorted Over Time

Beam Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202628,309,079 shares $880.98 million +31.9%28.6%14.22 $31.12
5/29/202621,455,853 shares $706.54 million -19.1%21.7%11.73 $32.93
5/15/202626,515,763 shares $740.59 million +26.7%26.8%12.57 $27.93
4/30/202620,936,705 shares $635.01 million -5.8%21.2%9.51 $30.33
4/15/202622,221,090 shares $681.74 million -4.9%22.5%11.05 $30.68
3/31/202623,361,096 shares $556.69 million +9.7%23.6%10.65 $23.83
3/13/202621,302,875 shares $535.98 million -2.7%21.7%10.61 $25.16
2/27/202621,890,367 shares $623.00 million +8.2%22.1%13.62 $28.46
2/13/202620,227,236 shares $564.74 million +4.2%20.4%13.49 $27.92
1/30/202619,409,310 shares $536.09 million -3.2%19.8%10.11 $27.62
1/15/202620,044,367 shares $642.42 million -1.2%20.5%8.55 $32.05
12/31/202520,295,552 shares $562.59 million +2.6%20.7%15.66 $27.72
12/15/202519,788,474 shares $530.92 million -5.6%20.2%10.94 $26.83
11/28/202520,951,122 shares $527.65 million +2.0%21.4%10.36 $25.19
11/14/202520,550,660 shares $446.36 million +3.7%21.0%8.66 $21.72
10/31/202519,823,221 shares $495.78 million -2.9%20.2%7.61 $25.01
10/15/202520,420,000 shares $555.22 million -4.5%20.9%7.8 $27.19
9/30/202521,380,000 shares $518.89 million -16.2%N/A8.4 $24.27
9/15/202525,500,000 shares $542.64 million +0.1%N/A9.7 $21.28
8/31/202525,480,000 shares $416.85 million -6.2%26.1%10.4 $16.36
8/15/202527,170,000 shares $484.17 million +10.4%N/A12 $17.82
7/31/202524,620,000 shares $485.26 million +4.1%25.2%11.7 $19.71
7/15/202523,660,000 shares $463.26 million -1.7%N/A11.3 $19.58
6/30/202524,080,000 shares $409.60 million +10.8%24.8%11 $17.01
6/15/202521,730,000 shares $370.71 million +2.7%22.4%9.8 $17.06
5/31/202521,160,000 shares $333.06 million +1.5%26.7%8.8 $15.74
5/15/202520,840,000 shares $359.49 million +8.2%26.3%8.9 $17.25
4/30/202519,260,000 shares $383.85 million +2.3%N/A8.2 $19.93
4/15/202518,830,000 shares $325.38 million +27.8%23.7%8.9 $17.28
3/31/202514,740,000 shares $287.87 million +21.2%18.6%7.4 $19.53
3/15/202512,160,000 shares $294.64 million +21.7%15.3%7.7 $24.23
2/28/20259,990,000 shares $263.14 million +8.1%12.6%7 $26.34
2/15/20259,240,000 shares $299.38 million -7.8%11.6%7.6 $32.40
1/31/202510,020,000 shares $259.72 million -7.1%N/A8.7 $25.92
1/15/202510,790,000 shares $252.38 million +9.8%N/A9.1 $23.39
12/31/20249,830,000 shares $243.78 million -2.3%N/A8.5 $24.80
12/15/202410,060,000 shares $280.98 million -5.8%N/A9.1 $27.93
11/30/202410,680,000 shares $292.31 million -10.8%N/A10.4 $27.37
11/15/202411,970,000 shares $287.88 million -2.8%N/A12.3 $24.05
10/31/202412,310,000 shares $269.71 million +10.3%N/A13.8 $21.91
Trump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel

See which companies control the supply chain behind this emerging tech
10/15/202411,160,000 shares $293.95 million -1.8%N/A12.6 $26.34
9/30/202411,360,000 shares $278.32 million +3.7%N/A11.8 $24.50
9/15/202410,960,000 shares $288.25 million -1.1%N/A10.3 $26.30
8/31/202411,080,000 shares $295.61 million -0.9%N/A9.2 $26.68
8/15/202411,180,000 shares $277.93 million -3.8%N/A8.9 $24.86
7/31/202411,620,000 shares $367.66 million -3.7%N/A8.9 $31.64
7/15/202412,060,000 shares $308.98 million +2.2%N/A8.7 $25.62
6/30/202411,800,000 shares $276.47 million -8.9%N/A8.7 $23.43
6/15/202412,950,000 shares $322.07 million -6.4%N/A9.7 $24.87
5/31/202413,830,000 shares $329.43 million -5.1%N/A11 $23.82
5/15/202414,580,000 shares $351.52 million +4.0%N/A10.2 $24.11
4/30/202414,020,000 shares $297.50 million +6.5%N/A9.3 $21.22
4/15/202413,170,000 shares $338.47 million -2.1%N/A8.4 $25.70
3/31/202413,450,000 shares $444.39 million -6.1%N/A9.7 $33.04
3/15/202414,320,000 shares $507.07 million +9.2%N/A10.1 $35.41
2/29/202413,110,000 shares $517.71 million -2.4%N/A9.2 $39.49
2/15/202413,430,000 shares $443.46 million +0.3%N/A9.6 $33.02
1/31/202413,390,000 shares $326.72 million +2.0%N/A9.7 $24.40
1/15/202413,130,000 shares $336.13 million -2.7%N/A8.7 $25.60
12/31/202313,490,000 shares $367.20 million +0.1%N/A9.4 $27.22
12/15/202313,480,000 shares $383.10 million +3.7%N/A9.5 $28.42
11/30/202313,000,000 shares $365.04 million -6.0%N/A9.8 $28.08
11/15/202313,830,000 shares $347.82 million -4.3%N/A11.1 $25.15
10/31/202314,450,000 shares $305.47 million -4.3%N/A13.6 $21.14
10/15/202315,100,000 shares $336.13 million +5.2%N/A16.3 $22.26
9/30/202314,350,000 shares $345.12 million +6.2%N/A16.5 $24.05
9/15/202313,510,000 shares $338.43 million +2.9%N/A16.1 $25.05
8/31/202313,130,000 shares $304.35 million +0.5%N/A15.8 $23.18
8/15/202313,060,000 shares $316.97 million +8.8%N/A15.8 $24.27
7/31/202312,000,000 shares $370.44 million -3.7%N/A14.1 $30.87
7/15/202312,460,000 shares $384.52 million -1.4%N/A15.1 $30.86
6/30/202312,630,000 shares $403.28 million +1.5%N/A15.3 $31.93
6/15/202312,450,000 shares $423.30 million -0.5%N/A14.6 $34.00
5/31/202312,510,000 shares $399.07 million -4.9%20.0%13.6 $31.90
5/15/202313,150,000 shares $473.27 million +3.3%21.0%13.4 $35.99
4/30/202312,730,000 shares $390.94 million -1.1%21.4%13.7 $30.71
4/15/202312,870,000 shares $402.44 million -5.4%21.7%13.8 $31.27
3/31/202313,610,000 shares $416.74 million -2.2%22.9%14.6 $30.62
3/15/202313,910,000 shares $488.24 million +11.5%23.5%15.3 $35.10
2/28/202312,480,000 shares $502.20 million +4.4%21.1%14.9 $40.24
2/15/202311,950,000 shares $525.08 million -3.8%20.7%15.2 $43.94
1/31/202312,420,000 shares $539.65 million -4.5%21.5%14.8 $43.45
1/15/202313,010,000 shares $562.55 million +9.0%22.6%15.6 $43.24
12/30/202211,940,000 shares $466.97 million +1.7%20.7%14.3 $39.11
12/15/202211,740,000 shares $496.72 million -5.6%20.4%13.9 $42.31
11/30/202212,440,000 shares $574.60 million -4.4%21.6%14 $46.19
11/15/202213,010,000 shares $639.83 million -0.7%22.6%13.8 $49.18
10/31/202213,100,000 shares $577.19 million +0.2%23.8%12.2 $44.06
10/15/202213,080,000 shares $594.75 million -0.3%23.8%12.2 $45.47
9/30/202213,120,000 shares $625.04 million +5.8%23.9%11.3 $47.64
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
9/15/202212,400,000 shares $750.08 million +2.1%22.6%10 $60.49
8/31/202212,140,000 shares $662.84 million +0.1%22.1%9.3 $54.60
8/15/202212,130,000 shares $852.86 million -6.5%22.1%9.2 $70.31
7/31/202212,970,000 shares $816.85 million -2.0%22.8%9.5 $62.98
7/15/202213,240,000 shares $762.89 million +3.4%23.3%9.5 $57.62
6/30/202212,810,000 shares $495.88 million +10.2%22.6%9.4 $38.71
6/15/202211,620,000 shares $371.26 million +4.6%20.5%8.7 $31.95
5/31/202211,110,000 shares $390.85 million -4.9%19.7%9.1 $35.18
5/15/202211,680,000 shares $414.06 million +8.1%21.7%9.9 $35.45
4/30/202210,810,000 shares $405.70 million +10.5%20.1%10.3 $37.53
4/15/20229,780,000 shares $453.79 million +10.9%18.5%9.3 $46.40
3/31/20228,820,000 shares $505.39 million +3.6%16.9%8.4 $57.30
3/15/20228,510,000 shares $470.09 million -3.6%16.3%9.1 $55.24
2/28/20228,830,000 shares $691.83 million +7.6%17.1%9.8 $78.35
2/15/20228,210,000 shares $606.47 million +4.7%15.9%9.5 $73.87
1/31/20227,840,000 shares $542.61 million +26.5%15.2%9.7 $69.21
1/15/20226,200,000 shares $420.48 million +11.3%11.5%8.8 $67.82
12/31/20215,570,000 shares $443.87 million +1.1%10.4%9.5 $79.69
12/15/20215,510,000 shares $443.72 million +5.6%10.2%9.3 $80.53
11/30/20215,220,000 shares $413.16 million +7.6%9.8%8.6 $79.15
11/15/20214,850,000 shares $419.23 million +3.9%9.1%8.1 $86.44
10/29/20214,670,000 shares $414.56 million -15.4%9.4%7.7 $88.77
10/15/20215,520,000 shares $514.13 million +9.5%11.2%8.7 $93.14
9/30/20215,040,000 shares $438.53 million -3.5%10.2%7.6 $87.01
9/15/20215,220,000 shares $533.01 million -5.6%10.6%6.3 $102.11
8/31/20215,530,000 shares $613.39 million +7.2%11.4%7 $110.92
8/13/20215,160,000 shares $521.26 million +2.8%10.8%6.5 $101.02
7/30/20215,020,000 shares $461.84 million +3.3%11.3%5.8 $92.00
7/15/20214,860,000 shares $415.77 million -9.0%10.9%5.6 $85.55

BEAM Short Interest - Frequently Asked Questions

Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 28,309,079 shares of BEAM short. 28.60% of Beam Therapeutics' shares are currently sold short. Learn More on Beam Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 14.2. Learn More on Beam Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 28.60% of Beam Therapeutics' floating shares are currently sold short.

Beam Therapeutics saw a increase in short interest in June. As of June 15th, there was short interest totaling 28,309,079 shares, an increase of 31.9% from the previous total of 21,455,853 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

28.60% of Beam Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Beam Therapeutics: CRISPR Therapeutics AG (28.79%), Denali Therapeutics Inc. (11.10%), Editas Medicine, Inc. (19.41%), Intellia Therapeutics, Inc. (37.32%), Prime Medicine, Inc. (21.45%), BridgeBio Pharma, Inc. (15.13%), Dr. Reddy's Laboratories Ltd (2.79%), Axsome Therapeutics, Inc. (8.03%), Elanco Animal Health Incorporated (7.20%), Arrowhead Pharmaceuticals, Inc. (8.65%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.25 billion), Invesco QQQ ($51.70 billion), iShares Russell 2000 ETF ($25.75 billion), Sandisk Corporation ($23.00 billion), Western Digital Corporation ($17.29 billion), Nebius Group N.V. ($13.25 billion), SPDR S&P Biotech ETF ($10.78 billion), KLA Corporation ($10.45 billion), Salesforce Inc. ($9.71 billion), and VanEck Semiconductor ETF ($9.01 billion). View all of the most shorted stocks.

Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading down $1.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is June, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BEAM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:BEAM) was last updated on 6/25/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel